FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Aurobindo Pharma Pantoprazole Sodium for Injection Recall

Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd

Aurobindo Pharma USA Inc · Plainsboro, NJ

Risk level
Class III
Reported by FDA
Feb 15, 2017
Recall ID
D-0470-2017
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Pantoprazole Sodium for Injection starting Dec 16, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0470-2017 on Feb 15, 2017. Reason: Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance. Status: Terminated.

Why it was recalled

Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.

Product description

Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00

Lot numbers, UPCs & expiration codes

Lot #: CPO160028, Exp. June 2018

Where it was sold

Nationwide in US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0470-2017
Classification
Class III
Status
Terminated
Recall initiated
Dec 16, 2016
FDA report date
Feb 15, 2017
Quantity
29800 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc

Original FDA data

Every field from FDA enforcement report D-0470-2017, exactly as published.

Show all FDA fields
City
Plainsboro
State
NJ
Status
Terminated
Country
United States
Event ID
75997
Address
666 Plainsboro Rd Ste 210
Code information
Lot #: CPO160028, Exp. June 2018
Postal code
08536-3004
Report date
Feb 15, 2017
Product type
Drugs
Recall number
D-0470-2017
Classification
Class III
Recalling firm
Aurobindo Pharma USA Inc
Product quantity
29800 vials
Termination date
Jul 29, 2020
Reason for recall
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00
Distribution pattern
Nationwide in US
Recall initiation date
Dec 16, 2016
Initial firm notification
Letter
Center classification date
Feb 8, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0470-2017, published Feb 15, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls